FDA Device Intelligence
HomeINSTRUMENTATION LABORATORY COMPANY › HemosIL Factor Diluent

HemosIL Factor Diluent

INSTRUMENTATION LABORATORY COMPANY · Model 00009757600 · UDI-DI 08426950062295

GKP Prescription
10
510(k) clearances
661
Adverse events (13 deaths)
31
Recalls
17
Facilities

Description

HemosIL Factor Diluent 100 mL

Recalls

DateFirmReason
2023-07-13Instrumentation LaboratorySample misidentification could occur under specific conditions and patient management altered based on an incorrectly assigned result
2022-02-22Instrumentation LaboratoryUpdated and revised user instructions issued 7/14/22. Potential carryover issue may cause elevated quality control and sample results for heparin, apixaban or rivaroxaban when Hemo
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2014-06-03Instrumentation Laboratory Co.Potential for sample misidentification.
2013-07-19Instrumentation Laboratory Co.Potential carryover issue that can can cause shortened APTT clotting times on the instrument.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.